Cyclophosphamide 100 mg inj
This code is not in the latest file (4Q26). It was last listed in 1Q24.
Payment limit per 100 MG, by effective quarter, 1Q21 to 1Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.This code is not in the latest file (4Q26). It was last listed in 1Q24.
Payment limit per 100 MG, by effective quarter, 1Q21 to 1Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.No NDCs mapped to this code in the 4Q26 crosswalk.
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 1Q24 | $20.153 | +$2.211 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted December 19, 2024 |
| 4Q23 | $17.942 | +$0.855 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted October 10, 2024 |
| 3Q23 | $17.087 | −$4.55 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted June 5, 2024 |
| 2Q23 | $21.637 | −$0.494 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted February 23, 2024 |
| 1Q23 | $22.131 | +$0.208 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted December 6, 2023 |
| 4Q22 | $21.923 | −$4.947 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted June 22, 2023 |
| 3Q22 | $26.87 | +$2.99 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted June 9, 2023 |
| 2Q22 | $23.88 | −$3.593 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted December 14, 2022 |
| 1Q22 | $27.473 | −$1.68 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted June 8, 2022 |
| 4Q21 | $29.153 | −$1.844 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted June 2, 2022 |
| 3Q21 | $30.997 | +$0.109 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted June 2, 2022 |
| 2Q21 | $30.888 | −$0.276 | 100 MG | Cyclophosphamide 100 mg inj | v1, posted March 1, 2022 |
| 1Q21 | $31.164 | – | 100 MG | Cyclophosphamide 100 mg inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.